Coffee & Compatibility
By American Society for Histocompatibility & Immunogenetics
Coffee & CompatibilityDec 19, 2022
Organ allocation in the U.S.
Organ allocation expert Larry Suplee joins Coffee & Compatibility to discuss the strengths of the U.S. organ allocation system and explore future improvements.
An ASHI Pioneer revisits wonderful ASHI Memories: Happy 50th ASHI!
Trailblazer Donna Phelan shares her journey in HLA including moments of special connection with ASHI’s mission, groundbreaking advances in technology, and paving the way for technologist leadership in ASHI!
Look how far we’ve come!
Kicking off a celebration of ASHI’s 50th anniversary, the podcast welcomes Dr. Carolyn Hurley for a conversation about the history and future of ASHI.
Accuracy in anti-HLA antibody identification assay analysis
Coffee & Compatibility jumps into 2024 with Dr. Robert Liwski, who will give best practices advice on ruling spurious reactivity out of your antibody detection assays. This is your opportunity to up your antibody data accuracy game in 2024!
New State Law aims to grow The Organ Donor Registry!
Patrick Wells-O’Brien joins the podcast to discuss a new law in Michigan designed to grow the organ donor registry and how you can initiate similar legislation in your state.
Coffee & Compatibility remembers the call to action from 2-time heart recipient, Amy Silverstein
Our special guest, transplant pharmacist, Dr. Reed Hall, joins us to honor the memory of transplant patient advocate, Amy Silverstein, and do discuss her concerns regarding the need for innovation in immunosuppressing transplant patients.
ASHI’s Lab Professionals Recruitment Task Force
Dr. Cathy Gebhart and Cordy Kudika explain what ASHI is doing to attract lab professionals, engage students, and spark greater interest in histocompatibility and immunogenetics as a career!
Live from the 2023 ASHI Annual Meeting
Drs. Cathi Murphey and Michael Gautreaux join the show and share their unique perspectives on dual HLA typing for deceased donors
Growing your professional network!
Join Kelley, Eric, and Jeremy as they share stories and discuss the exciting networking opportunities at the ASHI Annual Meeting!
Future Omic’s in Personalized Medicine
An interview with Drs. Sharoni Jacobs and James Lu, from Helix, Inc. on the role of Omic technologies in modern medicine and the future opportunities it opens for the ASHI community.
The Resident’s Starting Point
What do medical residents already know about HLA when they rotate through our labs and what do they hope to gain? Dr. Shasta Theodore, a pathology resident, shares her perspective as she begins her histocompatibility lab rotation.
HLA Clinical Laboratories and BMT/HSCT Service
Dr. Maria Bettinotti stresses the importance of HLA consultation for optimal clinical service to bone marrow and hematopoietic stem cell transplant programs. Join us to learn more about “best practices” in BMT/HSCT HLA testing and clinical consultation.
The ASHI Annual Meeting and why you should go!
Step into the world of event planning magic with this episode featuring ASHI Meeting Manager, Stephanie Ritter. Learn more about the engaging workshops, networking receptions, and how this year's ASHI Annual Meeting is an event you don't want to miss!
Innovation in U.S. lung allocation
The Chair and past-Chair of the UNOS/OPTN Lung Committee, Dr. Erika Lease and Dr. Marie Budev, join Coffee & Compatibility to discuss the innovative changes in the new deceased donor lung allocation model in the United States. Join us to learn about the advances and challenges in lung allocation.
Using continuing education to advance your career with Phillip Fisher
The podcast team hosts Phillip Fisher for a discussion on creative continuing education opportunities that can advance your career.
Progress and Innovation in solid organ allocation equity
Dr. James Lan joins Coffee & Compatibility to continue the discussion on equity and innovation in solid organ transplantation. Register for the 2023 ASHI Annual Meeting by clicking here: https://2023.ashi-hla.org/registration
Next-generation sequencing (NGS) with Mr. John Sadowski
On this episode, we talked with Mr. John Sadowski, the Lead Technologist at UPMC for Next-Generation Sequencing (NGS). Mr. Sadowski performed beta testing of the Oxford Nanopore System for HLA sequencing and he walks us through how nanopore sequencing works and names the advantages and disadvantages compared to other sequencing methods.
Algorithmic approaches to open allocation - Part 1
Dr. Loren Gragert discusses recent and future data tools developed to enhance and optimize solid organ transplant offer assessments and tools on the horizon, as well as the system updates that will be vital to their future applications.
Carving your path through ASHI: A technologist’s perspective with Sharon Adams
In this episode, we interview Sharon Adams about her career in HLA, overcoming common challenges faced by technologists, and her advice for the next generation.
Carving your path through ASHI: An interview with Dr. Nicholas Brown
This episode of Coffee & Compatibility is dedicated to Tyler Douglas Weeks, son of ASHI's Accreditation Manager, Melissa Weeks, who passed away on April 5, 2023. In lieu of flowers, the family has asked for donations to the 1p36 deletion syndrome association in Tyler’s memory. It's Medical Laboratory's Professionals Week! Click here to learn more about how you can celebrate with ASHI, and win prizes! On this episode we discuss how Dr. Nicholas Brown has made his way within ASHI. Dr. Brown discusses how he went from Fellow to Director, his leadership experience at ASHI, and balancing volunteer commitments. On our newest segment "The Tea", we answer a listener's questions on NMDP's organ allocation system.
Don't forget to hit the subscribe button!
Race, Ethnicity, Ancestry, and how they impact HLA Genotyping
We introduce our new co-host, Mr. Jeremy Sherrill! In an interview with Bioinformatician Dr. Abeer Madouly, we discuss the evolving role of race, ethnicity, and ancestry in the field of immunogenetics. Dr. Madouly discusses how and why they are used in HLA genotyping now and in the future. We also answer a question from listener regarding CHS testing in our newest segment, The Tea.
Evolution of donor selection in Hematopoietic Stem Cell Transplantation (HSCT)
In this episode, we dive into the considerations behind choosing HLA-matched vs. haplo-identical HSCT donors and the clinical innovations that are driving increases in haplo-identical HSCT.
A different take on virtual crossmatch use in the U.S.
In this episode we are joined by Dr. Sam Ho for a discussion on how virtual crossmatch is being utilized in different laboratory models in the U.S. and how requests for federal regulatory changes and organ allocation models are impacting its future application.
Algorithm development and discussion with PIRCHE VP Matthias Niemann
Discussion on the development of Machine Learning approaches and advancements within the ML/AI technology towards application with transplantation.
Live from the 2022 ASHI Annual Meeting
Check out this live recording of Coffee & Compatibility from the 2022 ASHI Annual Meeting. Podcast hosts Drs. Eric Weimer and Kelley Hitchman interview ASHI's CEO Ms. Katherine Giovetsis, Dr. Peter Lalli, Dr. Luis Hidalgo, and Ms. Carey Killion.
The Application and Design of Machine Learning in Healthcare
In this episode, Mr. James Nguyen, a Principal Cloud Solution Architect at Microsoft Azure, discusses the application and design of machine learning approaches to healthcare. He talks about how applying his years of experience with big data analytics to modern healthcare challenges can aid in the solution of complex challenges. Topics will include data engineering, data quality, and most importantly, how to get started.
The road to best practices in anti-HLA antibody testing
HLA Innovators Dr. Robert Liwski, Dr. Annette Jackson and Dr. Anne Halpin set the stage for best practices in anti-HLA antibody testing and analysis on this special Coffee & Compatibility Episode. You do not want to miss this episode or the related session at this year’s ASHI annual meeting in Las Vegas, NV October 24-28.
Interview with Dr. Matthieu-P. Schapranow on the application of Artificial Intelligence
Join us and Dr. Matthieu-P. Schapranow of the NephroCAGE consortium, for an episode dedicated to the application of artificial intelligence and machine learning in transplant risk assessment.
VALID Act: Call to Action
In this short episode, we interviewed ASHI's government liaison representation Mr. James Fleischmann of Wheat-Shroyer Government Relations firm and ASHI Board Member Dr. Cathi Murphy to discuss concerns regarding the VALID Act and what you can do to help.
Concerns in Sickle Cell Disease with Dr. Yvette Miller
In this very salient episode, Dr. Yvette Miller guides us through current concerns in Sickle Cell Disease, the dire need for African American blood donor recruitment and the needs for the medical community to work harder to earn trust, and focus equity and access, in disadvantaged populations.
S.T.A.R. Workgroup series, episode 3: Non-HLA Antibody Testing
Join us for the third and final episode of our series on the progress of the Sensitization in Transplantation: Assessment of Risk (STAR) workgroup. Dr. Michelle Hickey joins us to discuss perhaps the newest and most controversial STAR workgroup sub-study, non-HLA antibody testing and diagnostics.
S.T.A.R. Workgroup series, episode 2: Alloimmunity
Join us for the second episode of our series on the progress of the Sensitization in Transplantation: Assessment of Risk (STAR) workgroup. During this second episode of the STAR workgroup series we are joined by Dr. David Pinelli for a discussion on alloimmunity and diagnostics.
S.T.A.R. Workgroup Series, Episode 1: Histocompatibility Testing in Clinical Trials
Join us for the first in a multi-episode series on the progress of the Sensitization in Transplantation: Assessment of Risk (STAR) workgroup. In the first episode of the STAR workgroup series, we discuss progress in the utility of anti-HLA antibody testing in clinical trials with Dr. Nicole Valenzuela.
Government relations in clinical laboratory science
Ms. Julie Shroyer and Mr. James Fleischmann, of Wheat Shroyer Government Relations, join Coffee & Compatibility to describe what it is like to be ASHI’s eyes and ears in Washington D.C. and to let our listeners in on current legislation impacting clinical laboratory science.
Interview with Dr. Alexandre Loupy
In this episode, Dr. Alexandre Loupy discusses his group’s recent discoveries and insights into biomarker discovery for transplant patients.
Interview with Dr. Robert Montgomery
Tune in for a very special episode with Dr. Robert Montgomery. Dr. Montgomery is the Professor of Surgery and Director of the NYU Langone Transplant Institute. For over a decade he served as the Chief of Transplant Surgery and the Director of the Comprehensive Transplant Center at Johns Hopkins.
Wrapping up 2021
Coffee and Compatibility hosts Eric and Kelley recap their first year as podcasters. Tune in to hear about their favorite episodes, hosting the ASHI Annual Meeting, and what happens behind the scenes.
The field of bioinformatics
Guest Dr. Abeer Madbouly explains the field of bioinformatics and how it has the potential to shape the future of histocompatibility and immunogenetics.
Live at the 2021 ASHI Annual Meeting
Check out the live episode of Coffee & Compatibility at the 2021 ASHI Annual Meeting in Orlando with special guests:
Executive Producer and ASHI Chief Operating Officer Mandi Cruz
ASHI President-elect Dr. Robert Liwiski
2021 J Marilyn MacQueen Rising Star Award recipient Dylan Smith
Professor of Surgery & Epidemiology and Associate Vice Chair of Surgery at Johns Hopkins University Dr. Dorry Segev
T-Cell Epitopes
Dr. Massimo Mangiola, of NYU, joins us to explain the differences between epitopes and eplets, the current state of eplet research in transplantation risk assessment and how this work is shaping the future of transplant compatibility considerations.
Utilization of killer cell immunoglobulin–like receptor (KIR) testing in transplantation
This episode will explore killer cell immunoglobulin-like receptor (KIR) testing in solid organ and hematopoietic cell transplantation with experts Drs. Paula Arnold and Luis Hidalgo. We will explore recent literature on KIR utility in clinical decision-making.
Controversies in HLA
This episode will cover some hot topic issues facing immunogenetic laboratories. Tune in to hear from ASHI's President-elect Dr. Annette Jackson as she discusses various controversies within transplant diagnostics and ways to improve patient focused testing.
The Field of HLA: The Technologist Perspective
With TWO special guests this episode, Coffee & Compatibility is back! Mr. Walter Herczyk and Ms. Doreen Sese join us as we dive into the future of the HLA field from the technologist perspective.
Exploring the upcoming 47th ASHI Hybrid Annual Meeting
This episode will explore the upcoming 47th ASHI Hybrid Annual Meeting with the Chair of the ASHI Program Planning Committee and Past ASHI President Medhat Askar, MD, PhD.
ASHI celebrates Lab Week and Donate Life Month 2021
In honor of Donate Life Month and in celebration of Lab Week 2021, we explore two aspects of transplantation that heavily impact HLA Laboratory practice. Join us as we chat with Mr. Jeffrey Orlowski, CEO of LifeShare Oklahoma, about how changes in donor procurement and organ allocation are shaping the future of transplantation and HLA practice. We even have a 2nd guest, not to be missed! Ms. Amy Silverstein, author and 2 time heart transplant recipient, will discuss patient perspectives on HLA testing, recent medically directed legislation, and more. Tune in to hear the latest perspectives on donor and patient care in transplantation.
Interview with Editor in Chief of Human Immunology, Dr. Amy Hahn
In this episode, you’ll hear from Human Immunology Editor-in-Chief, Dr. Amy Hahn, as she discusses her role at Human Immunology, various aspects of the peer review process, and the recent announcement of award-winning papers.
COVID-19 Vaccine Information
An interview with Dr. Cindy Gay, MD, MPH, UNC Infectious Disease Physician and UNC site PI for Moderna and Novavax phase 3 COVID-19 vaccine trials. Dr. Gay will discuss the vaccine trials and vaccine safety.
Interview with ASHI President Dr. William Hildebrand
In this episode, you’ll hear from ASHI President Dr. William Hildebrand as he discusses his career path to HLA, his goals for the Society, and the additional directions in HLA including immuno-oncology, autoimmune therapies and infectious disease.
Trailer
The American Society for Histocompatibility and Immunogenetics is hosting a podcast! Tune in to hear about how the podcast got started and what you can expect from future episodes.